Cargando…

G3P - Good Privacy Protection Practice in Clinical Research : Principles of Pseudonymization and Anonymization.

Medical and genetic information from medical research must be protected against unauthorized access and replication. This book is a practical guide demonstrating how coding methods, providing the required high degree of data protection, can be integrated into respective applications dealing with pat...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Schriever, Karl-Heinz
Otros Autores: Schröder, Markus
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Berlin/Boston : De Gruyter, 2014.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Mi 4500
001 EBSCO_ocn898769669
003 OCoLC
005 20231017213018.0
006 m o d
007 cr |n|||||||||
008 141227s2014 mau ob 001 0 eng d
010 |a  2014017116 
040 |a EBLCP  |b eng  |e pn  |c EBLCP  |d OCLCQ  |d YDXCP  |d E7B  |d CCO  |d OCLCO  |d DEBSZ  |d OCLCQ  |d AZK  |d OCLCQ  |d COCUF  |d PIFAG  |d ZCU  |d MERUC  |d DEGRU  |d U3W  |d UIU  |d STF  |d OCLCF  |d OCLCQ  |d ICG  |d VT2  |d OCLCO  |d OCLCQ  |d WYU  |d OCLCA  |d TKN  |d LEAUB  |d DKC  |d OCLCO  |d OCLCQ  |d UX1  |d OCLCQ  |d N$T  |d OCLCA  |d K6U  |d U9X  |d VLY  |d AUD  |d BRF  |d OCLCQ  |d OCLCO  |d OCL  |d OCLCQ  |d QGK  |d OCLCO 
019 |a 899591384  |a 961511398  |a 962631912  |a 979584791  |a 1055394992  |a 1066651588  |a 1081296984  |a 1107345909  |a 1162496816  |a 1228564800  |a 1259054791 
020 |a 311028328X 
020 |a 9783110283297 
020 |a 3110283298 
020 |a 9783110283280  |q (electronic bk.) 
020 |z 9783110367645 
020 |z 3110367645 
020 |a 3110381591 
020 |a 9783110381597 
024 7 |a 10.1515/9783110283280  |2 doi 
029 1 |a AU@  |b 000056057008 
029 1 |a DEBBG  |b BV044068149 
029 1 |a DEBSZ  |b 43481119X 
035 |a (OCoLC)898769669  |z (OCoLC)899591384  |z (OCoLC)961511398  |z (OCoLC)962631912  |z (OCoLC)979584791  |z (OCoLC)1055394992  |z (OCoLC)1066651588  |z (OCoLC)1081296984  |z (OCoLC)1107345909  |z (OCoLC)1162496816  |z (OCoLC)1228564800  |z (OCoLC)1259054791 
050 4 |a R853.C55  |b S37 2014eb 
060 4 |a W 20.5 
072 7 |a MED106000  |2 bisacsh 
082 0 4 |a 610.72/4  |2 23 
084 |a PZ 4700  |2 rvk 
049 |a UAMI 
100 1 |a Schriever, Karl-Heinz. 
245 1 0 |a G3P - Good Privacy Protection Practice in Clinical Research :  |b Principles of Pseudonymization and Anonymization. 
260 |a Berlin/Boston :  |b De Gruyter,  |c 2014. 
300 |a 1 online resource (210 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
588 0 |a Print version record. 
505 0 |a About the Authors; 1 Introduction; 2 Study Modes; 2.1 Screening Mode -- Pharmacogenetic Information for Screening; 2.2 Pre- Unspecified Mode -- Pharmacogenetic as Part of a Study; 2.3 Possible Approaches, Summary -- Clinical Trial With Genetic Part; 2.4 Biobanks -- What do we Mean by That?; 3 Protection Masks and Procedures; 3.1 Identified Samples/Data; 3.2 De-identified Samples/Data; 3.3 Anonymized Samples/Data; 3.4 Re-identification; 4 Coding Methods for De-identified Samples/Data; 4.1 Single-coded Samples/Data; 4.2 Double-coded Samples/Data; 4.3 Triple-coded Samples/Data. 
505 8 |a 5 Relationships Among the Protection Masks6 Data Types; 7 Anonymization; 7.1 Basic Terms and Ideas; 7.2 Masking; 7.3 Discarding the Key; 7.4 Maintaining the Reliability of Stored Data; 7.5 Security Measures; 8 Validation -- a Brief Introduction; 8.1 Preliminaries; 8.2 Basic Definitions & Terms; 8.3 General Principles of Computer System Validation; 8.4 Primary Validation -- Specification Phase; 8.5 Primary Validation -- Preparing Operational Use; 8.6 Primary Validation -- Testing Phase; 9 Request Management; 9.1 Genetic Review Board (GRB); 9.2 Request Specification; 9.3 Subrequest Specification. 
505 8 |a 9.4 Involvement of External Service Providers10 Legal Requirements & Regulations; 10.1 Basic Ideas; 10.2 Data Protection in the European Union (EU); 10.3 Transfer of Personal Data to Third Countries; 10.4 Binding Corporate Rules; 10.5 Data Protection in the United States (U.S.) -- a Brief History; 11 Informed Consent; 11.1 Sections Mandatory for a Genetic Informed Consent; 12 Selected Data Protection & Medical Sites; 12.1 Germany; 12.2 Europe; 12.3 US; 12.4 Global Initiatives; 13 Impact of External Services on Data Protection; 13.1 Introduction; 13.2 Scenario 1 -- Using GDI Throughout. 
505 8 |a 13.3 Scenario 2 -- Replacing GDI by nGDI Upon Sample Registration, Performed by regCRO13.4 Scenario 3 -- Replacing GDI by nGDI Upon Sample Registration, Performed by Sponsor; 13.5 Scenario 4 -- Sample Registration by CRO, Proprietary Labeling with CROSID; 13.6 Scenario 5 -- Barcoded Label bSID at Study Site; 13.7 Overall Summary; 13.8 External Statistical Evaluation; 13.9 External Biobanking; 14 Practical Approach to Clinical Trials with Supplementary Genetic Parts; 14.1 Introduction; 14.2 Overall Project Topology; 14.3 Checklist -- Trial Set-up; 14.4 Checklist -- System Topology. 
505 8 |a 14.5 Checklist -- Sample Management14.6 Checklist -- ICs, Ethics Committees Restrictions; 14.7 Checklist -- Anonymization; 14.8 Checklist -- Statistical Evaluation; 15 Appendix 1: Data Protection in the European Union; 15.1 Council of Europe (COE); 15.2 EU Privacy Directive -- Definitions; 15.3 Tasks of the Article 29 Data Protection Working Party; 16 Appendix 2: Data Types; 16.1 EU Privacy Directive (October 24, 1995); 16.2 Council of Europe (COE) Definition of Data Types; 16.3 Federal Data Protection Act (GER) as of 1. Jan. 2003; 17 Appendix 3: Protection Masks. 
500 |a 17.1 EMA definition of anonymous sample/data. 
520 |a Medical and genetic information from medical research must be protected against unauthorized access and replication. This book is a practical guide demonstrating how coding methods, providing the required high degree of data protection, can be integrated into respective applications dealing with patient related medical and genetic data. 
504 |a Includes bibliographical references (pages 191-196) and index. 
546 |a English. 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
650 0 |a Clinical trials  |x Research. 
650 0 |a Data protection. 
650 0 |a Medical care  |x Research. 
650 0 |a Medical records  |x Access control. 
650 0 |a Privacy, Right of. 
650 0 |a Confidential communications. 
650 1 2 |a Biomedical Research 
650 2 2 |a Anonymous Testing 
650 2 2 |a Confidentiality 
650 2 2 |a Privacy 
650 6 |a Études cliniques  |x Recherche. 
650 6 |a Protection de l'information (Informatique) 
650 6 |a Soins médicaux  |x Recherche. 
650 6 |a Dossiers médicaux  |x Accès  |x Contrôle. 
650 6 |a Secret professionnel. 
650 7 |a MEDICAL / Research.  |2 bisacsh 
650 7 |a Confidential communications  |2 fast 
650 7 |a Data protection  |2 fast 
650 7 |a Medical care  |x Research  |2 fast 
650 7 |a Medical records  |x Access control  |2 fast 
650 7 |a Privacy, Right of  |2 fast 
650 7 |a Medizin  |2 gnd 
650 7 |a Datenschutz  |2 gnd 
700 1 |a Schröder, Markus. 
776 0 8 |i Print version:  |a Schriever, Karl-Heinz.  |t G3P - Good Privacy Protection Practice in Clinical Research : Principles of Pseudonymization and Anonymization.  |d Berlin/Boston : De Gruyter, ©2014  |z 9783110367645 
856 4 0 |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=909994  |z Texto completo 
938 |a De Gruyter  |b DEGR  |n 9783110283280 
938 |a EBL - Ebook Library  |b EBLB  |n EBL1685362 
938 |a ebrary  |b EBRY  |n ebr11006632 
938 |a YBP Library Services  |b YANK  |n 11725008 
938 |a EBSCOhost  |b EBSC  |n 909994 
994 |a 92  |b IZTAP